SOLV Stock Analysis: Buy, Sell, or Hold?
SOLV - Solventum Corporation
$63.31
0.55 (0.87%)
▲
5d:
-3.63%
30d:
-14.68%
90d:
-21.32%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When SOLV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SOLV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SOLV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$113.51
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$70.48
10.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SOLV is currently trading at $63.30, which is considered oversold relative to its 30-day fair value range of $65.72 to $73.34. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.9) compared to its historical average (11.8). Remarkably, the market is currently pricing in an annual earnings decline of 8.9% over the next few years. This pessimistic expectation contrasts with the company's recent 100.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SOLV is in a downtrend. The price is currently testing key support at $62.65. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SOLV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $86.58 (+38.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SOLV is in a downtrend. The price is currently testing key support at $62.65. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SOLV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $86.58 (+38.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$65.72 -
$73.34
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 38.0% below Wall St target ($86.58)
Fair Price Analysis
30-Day Fair Range
$65.72 -
$73.34
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$62.65
Resistance Level
$69.11
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.91
Wall Street Target
$86.58
(+38.0%)
Revenue Growth (YoY)
-3.7%
Earnings Growth (YoY)
100.8%
Profit Margin
18.7%
Valuation Discount vs History
-8.9% cheaper
PE vs Historical
8.9 vs 11.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.9%
(market-implied from PE analysis)
1-Year Target
$57.17
(-9%)
2-Year Target
$52.09
(-17%)
3-Year Target
$47.45
(-24%)
3-Yr Target (if PE normalizes)
(PE: 9→12)
$62.83
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 8.9%)
$203.92
(+225%)
Base:
(SPY PE: 8.9, Growth: 8.9%)
$81.13
(+29%)
Bear:
(PE: 7.6, Growth: 8.9%)
$68.96
(+10%)
📈
Valuation based on Current Earnings
Trailing PE: 7.41 | Current EPS (TTM): $8.88
Bull Case
$57.75
(-12%)
Analyst growth -20.2%, PE expands to 8.2
Base Case
$52.50
(-20%)
Market implied -20.2%, PE stable at 7.4
Bear Case
$44.73
(-32%)
Severe decline -20.0%, PE contracts to 6.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.9 to 11.8
Stabilization Target:
$83.10
(+32.4%)
PE Expansion Potential:
+32.4%
Share & Embed Analysis
Last updated: March 30, 2026 2:53 PM ET
Data refreshes hourly during market hours. Next update: 3:53 PM
Data refreshes hourly during market hours. Next update: 3:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SOLV showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Amy Mcbride Wendell
BUY
1475 shares
2026-03-10
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 55 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 55 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 57 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 63 BUY |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$11 | 61 BUY |
